tirzepatide and psoriatic arthritis Concomitant ixekizumab significantly improved disease activity and promoted weight reduction versus ixekizumab alone in adults with PsA and obesity or overweight in the TOGETHER-PsA phase 3b trial. Read Scratching the Surface: The Latest

Good summaries highlight endpoints, population characteristics, duration, and what the numbers actually mean for everyday life

Thorough, extensive consultations

Weight loss was greater in female participants (up to 30.8%) than male participants (23.2%) at 80 weeks, a sex difference consistent with Phase 2 findings according to Dr

Frequently Asked Questions Why is the Wolverine Stack 1:1 BPC-157 to TB-500

Its worth noting that some people with PCD have few or no symptoms, and may go their entire life without being diagnosed this makes it difficult to know the exact number of people with all types of PCD

This enables modelling rotation through quadratic constraints